Orlando
Report: Leeds now want to sign £18m ‘new Lukaku’
Leeds United are interested in signing Orlando City powerhouse Daryl Dike this summer according to a report from TEAMtalk. Whites boss Marcelo Bielsa desperately needs to add some more firepower to his ranks at Elland Road before the transfer window slams shut. Providing more quality competition and cover for Patrick Bamford will be crucial to Leeds’ hopes of achieving success this season. And it seems as though Bielsa has his sights set on the perfect man for the job. Leeds are allegedly eyeing a move to sign Orlando City striker Dike – Copyright: xScottxColemanx Leeds eyeing Dike swoop TEAMtalk reckon that Bielsa is eyeing a move to bring the United States international to Elland Road this summer. Dike would be a fine addition for the Whites. The 21-year-old could be available for around...
US election: Republicans hold back Democrats, narrowing path to Senate control
The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...
Gold rises on renewed US stimulus hope, dollar falls
Spot gold rose 0.3 percent to $1,910.56 an ounce at 3:37pm, New York time, after falling as much as 0.5 percent. Gold rose on renewed optimism for a preelection aid package in the U.S., while the dollar fell to a one-week low. House Speaker Nancy Pelosi said a bill for a compromise stimulus package is being written as she awaits a key phone call with Treasury Secretary Steven Mnuchin. Senate Majority Leader Mitch McConnell said his chamber would take up a comprehensive coronavirus package if an accord is struck. The Bloomberg Dollar Spot Index headed for the third straight decline. Pelosi said in a Bloomberg Television interview that while there are areas where more work is required to get a compromise, she was pleased with the Trump administration’s latest position on coronavirus testing ...
NBA to resume games after player protest, turn stadiums into voting sites
NBA players who boycotted games as part of a protest against racial injustice have agreed to resume the playoffs on Saturday in a deal that includes increased access to voting in the United States presidential election. The league and players association (NBPA) said on Friday. As part of the agreement, the NBA and its players will establish a coalition that will focus on access to voting for the Nov. 3 general election, promoting civic engagement, and advocating for meaningful police and criminal justice reform. “These commitments follow months of close collaboration around designing a safe and healthy environment to restart the NBA season, providing a platform to promote social justice, as well as creating an NBA Foundation focused on economic empowerment in the Black community,” NBA Comm...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
